title: Selection of test methods to be included in a testing strategy to predict acute oral toxicity: an approach based on statistical analysis of data collected in phase 1 of the ACuteTox project.
abstract: More than 50 different in vitro and in silico methods assessing specific organ- and system-toxicity, such as haemato-, neuro-, nephro- and hepatotoxicity, as well as intestinal absorption, distribution and metabolism, have been used in the first phase of the ACuteTox project to test a common set of 57 chemicals. This paper describes the methods used for statistical evaluation of concentration-response data collected for each of the endpoint assays, and for the development of a testing strategy applicable for acute toxicity classification of chemicals based on the achieved results of the concentration-response analysis. A final list of in vitro test methods considered to be promising candidates for building blocks of the testing strategy is presented. Only these selected test methods were further investigated in the prevalidation phase of the project. The test methods were chosen according to their reproducibility and reliability and most importantly, according to their potential to classify chemicals into the official acute oral toxicity categories of the EU Classification, Labelling and Packaging (CLP) Regulation. The potential of the test methods to correctly classify the chemicals was assessed by Classification and Regression Trees (CART) analysis.
authors.affiliation: Institute for Health and Consumer Protection, Joint Research Centre, European Commission, Via Fermi 2749, 21027 Ispra, VA, Italy. agnieszka.kinsner@jrc.ec.europa.eu
authors.forename: A
authors.initials: A
authors.lastname: Kinsner-Ovaskainen
authors.forename: P
authors.initials: P
authors.lastname: Prieto
authors.forename: S
authors.initials: S
authors.lastname: Stanzel
authors.forename: A
authors.initials: A
authors.lastname: Kopp-Schneider
mesh_terms: D016475:3T3 Cells; D000110:Acetylcholinesterase / Q000378:metabolism; D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000378:metabolism; D053148:Caspase 3 / Q000235:genetics; D045744:Cell Line, Tumor; D002470:Cell Survival; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D016207:Cytokines / Q000378:metabolism; D003627:Data Interpretation, Statistical; D005312:Fetal Blood / Q000166:cytology; D015870:Gene Expression; D022781:Hepatocytes; D006801:Humans; D007928:Lethal Dose 50; D007963:Leukocytes, Mononuclear; D051379:Mice; D016571:Neural Networks, Computer; D009474:Neurons; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D018079:Receptors, GABA / Q000378:metabolism; D018570:Risk Assessment; D023382:Toxicity Tests, Acute / Q000379:methods*; D014529:Uridine / Q000378:metabolism
chemical_list: D016207:Cytokines; D012333:RNA, Messenger; D018079:Receptors, GABA; D000110:Acetylcholinesterase; D053148:Caspase 3; D014529:Uridine